Silverfin false false 30/11/2025 30/11/2025 01/12/2024 The principal activity of the company during the financial year was specialist medical practice activities and other human health activities. Dr Oliver Joseph Perkin 09/06/2022 Dr Beth Emily Wright 23/11/2020 13038759 2025-11-30 13038759 bus:Director1 2025-11-30 13038759 bus:Director2 2025-11-30 13038759 2024-11-30 13038759 core:CurrentFinancialInstruments 2025-11-30 13038759 core:CurrentFinancialInstruments 2024-11-30 13038759 core:Non-currentFinancialInstruments 2025-11-30 13038759 core:Non-currentFinancialInstruments 2024-11-30 13038759 2024-12-01 2025-11-30 13038759 bus:Micro-entities 2024-12-01 2025-11-30 13038759 bus:FilletedAccounts 2024-12-01 2025-11-30 13038759 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 13038759 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 13038759 bus:Director1 2024-12-01 2025-11-30 13038759 bus:Director2 2024-12-01 2025-11-30 13038759 2023-12-01 2024-11-30 iso4217:GBP xbrli:pure

Company No: 13038759 (England and Wales)

PERKSKIN LTD

Unaudited Financial Statements
For the financial year ended 30 November 2025
Pages for filing with the registrar

PERKSKIN LTD

UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 30 November 2025

Contents

PERKSKIN LTD

BALANCE SHEET

As at 30 November 2025
PERKSKIN LTD

BALANCE SHEET (continued)

For the financial year ended 30 November 2025
2025 2024
£ £
Fixed assets 136,094 63,871
Current assets 62,256 34,341
Creditors: amounts falling due within one year ( 60,212) ( 18,366)
Net current assets 2,044 15,975
Total assets less current liabilities 138,138 79,846
Creditors: amounts falling due after more than one year ( 44,147) ( 42,036)
Accruals and deferred income ( 1,714) ( 1,594)
Net assets 92,277 36,216
Capital and reserves 92,277 36,216

For the financial year ending 30 November 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Perkskin Ltd (registered number: 13038759) were approved and authorised for issue by the Board of Directors on 28 August 2026 and were signed on its behalf by:

Dr Beth Emily Wright
Director
PERKSKIN LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 November 2025
PERKSKIN LTD

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 30 November 2025

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 13038759). The address of its registered office is 5th Floor 25 King Street, Bristol, BS1 4PB, United Kingdom.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the financial year, including directors 2 2

3. Directors’ benefits: advances, credit and guarantees

Advances

The Directors loan account is repayable on demand and interest is charged on overdrawn balances at the official HMRC rate.

At 1 December 2024, the balance owed by the directors was £17,791. During the year, £6,731 was advanced to the directors, and £29,066 was repaid by the directors. At 30 November 2025, the balance owed to the directors was £4,543.

At 1 December 2023, the balance owed to the directors was £15,013. During the year, £36,805 was advanced to the directors, and £4,001 was repaid by the directors. At 30 November 2025, the balance owed by the directors was £17,791.